Biogen has launched a new app, CleoTM as an everyday digital companion to provide information and support for people living with multiple sclerosis (MS), as well as their carers, friends and family.
The Cleo App provides information, articles and stories for people living with MS and provides a simple way for MS patients to keep track of their health and set treatment and appointment reminders.
Users can also chat with a CleoTM Advisor who can help them make the most of CleoTM articles, programmes and features.
Terry O’Regan, Vice President & Managing Director, Biogen UK & Ireland “Biogen believes that, regardless of treatment choices, patients should always be informed, supported and inspired to aim for better tomorrows. CleoTM reinforces our ongoing commitment to MS and is an example of our ambition to provide digital solutions that bene t people living with neurological conditions.”
The app was developed by Biogen’s Global digital entity Biogen Healthcare Solutions. The app is already available in Germany, France, Italy, Canada, Japan and the US.
Matt Norcross, Af liate Head of Multichannel Excellence (UK) at Biogen “The MS journey is a complex one, and knowing where to go to nd trusted information on health and wellbeing can be a key challenge for patients in the UK. CleoTM was designed as a simple, personalised mobile solution to support the MS community in keeping track of their health, supporting their wellbeing and learning about the MS topics that matter most to them”